PAVmed announces 1-for-30 reverse stock split

* PAVmed (PAVM [https://seekingalpha.com/symbol/PAVM]) will conduct a 1-for-30 reverse stock split of its common stock, effective on January 2, 2026, at 12:01 a.m. Eastern Time.
* The reverse stock split is intended to bring the company into compliance with the $1.00 minimum bid price requirement for maintaining the listing of its common stock on Nasdaq.
* Following the split, the authorized shares of common stock will be reduced from 250M to 25M.
* PAVM -11.72% premarket to $0.25.
* Source: Press Release [https://seekingalpha.com/pr/20350464-pavmed-announces-reverse-stock-split]

MORE ON PAVMED, LUCID DIAGNOSTICS

* PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript [https://seekingalpha.com/article/4850721-pavmed-inc-pavm-shareholder-analyst-call-prepared-remarks-transcript]
* Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4844126-lucid-diagnostics-inc-2025-q3-results-earnings-call-presentation]
* PAVmed Inc. 2025 Q3 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4843956-pavmed-inc-2025-q3-results-earnings-call-presentation]
* Lucid Diagnostics signals imminent Medicare coverage for EsoGuard while strengthening commercial payer engagement [https://seekingalpha.com/news/4520823-lucid-diagnostics-signals-imminent-medicare-coverage-for-esoguard-while-strengthening]
* PAVmed Q3 2025 Earnings Preview [https://seekingalpha.com/news/4520627-pavmed-q3-2025-earnings-preview]